These findings were further validated in the independent Hartwig Medical Foundation cohort, where we observed significant increases in content (estimated via RNA-seq levels) of multiple CD8 + T-cell subsets in the lower iNMDeff tumors, across breast, kidney, lung, and skin cancers (Additional File 1: Fig. S28). Here, CD8A is linked to skin cancer.